Baiting, Gani B.
HRN: 23-29-01 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/04/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/04/2023
07/10/2023
IVT
500mg
Q8
T/c Complete Bowel Obstruction (volvulus:cecum)
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes